The Richmond, California-based company will be one of several biotech firms to list shares this year. Rate-cut expectations ...
Eli Lilly and Novo Nordisk compete in a handful of different markets ... is so intense in the U.S. that for months ...
Eli Lilly is intensifying its efforts to combat imitation versions of its popular appetite-suppressing drugs, Mounjaro and ...
In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against Goldman Sachs' other ...
Eli Lilly is cutting the cost of certain weight loss drugs, with new single-dose vials costing less than other medications ...
Eli Lilly (LLY) reached a key supply milestone Tuesday, announcing the launch of single-dose vials of Zepbound, one of ...
InvestingChannel on MSN4d
Eli Lilly and Company (LLY): Jim Cramer's Go-To Stock For SuccessWe recently compiled a list of the Jim Cramer's 10 Go-To Stocks for Success. In this article, we are going to take a look at ...
While Novo is struggling to keep up with demand for its obesity drugs, U.S. rival Eli Lilly sees supply restraints easing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback